1. 00054 CLINICAL RELEVANCE OF DOMINANT-NEGATIVE P73 ISOFORMS FOR RESPONSIVENESS TO CHEMOTHERAPY AND SURVIVAL IN OVARIAN CANCER - EVIDENCE FOR A CRUCIAL P53-P73 CROSS-TALK IN VIVO. (1st September 2005) Authors: Concin, N.; Hofstetter, G.; Berger, A.; Gehmacher, A.; Reimer, D.; Watrowsky, R.; Tong, D.; Hefler, L.; Heim, K.; Mueller-Holzner, E.; Marth, C.; Zeimet, A. G.; Moll, U.; Zeillinger, R. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material. (December 2022) Authors: Vladimer, G.; Alt, I.; Sehlke, R.; Lobley, A.; Baumgärtler, C.; Stulic, M.; Hackner, K.; Dzurillova, L.; Petru, E.; Hadjari, L.; Lafleur, J.; Singer, J.; Krall, N.; Šufliarsky, J.; Hefler, L.; Fuereder, T.; Taubert, C.; Boudesco, C.; Payne, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗